Skip to content

DOCTORS’ DAY

By bertrand

DOCTORS’ DAY The 30th of March was Doctors’ Day in the US! So regardless where they are, thanks to all doctors and cardiologists who are helping us treating non-invasively patients suffering from aortic stenosis. And thanks to all doctors and care professionals who have been mobilized for more than one year now to cure people … Continued

CLINICAL STUDY IN BREDA – MARCH 2021

By bertrand

CLINICAL STUDY IN BREDA – MARCH 2021 March 25, 2021 Two more patients affected by severe symptomatic Aortic Stenosis were treated in March with our non-invasive investigational device Valvosoft® in Breda, Netherlands. Congratulations to Amphia Hospital Teams and Dhr. dr. Bas Schölzel! Thanks Dr Guillaume Goudot from Hôpital Européen Georges-Pompidou – APHP for your support!

PLAN DEEPTECH

By bertrand

PLAN DEEPTECH Le Plan Deeptech a 2 ans ! Rejoignez la communauté Les Deeptech afin de fêter ensemble le progrès et l’innovation pour répondre aux enjeux de la société ! Cardiawave fait partie de la communauté Deeptech, et vous?

ANIMATION OF OUR DISRUPTIVE AND PATENTED TECHNOLOGY

By bertrand

ANIMATION OF OUR DISRUPTIVE AND PATENTED TECHNOLOGY March 16, 2021 Aortic stenosis is a life-threatening heart valve disease caused by the narrowing of the opening of the aortic valve leading to poor blood perfusion of the body. See the animation from DEMCON Nymus 3D to better understand how the valve is critically affected. See the … Continued

CARDIAWAVE’S FIRST-IN-HUMAN TRIAL – FUS FOUNDATION

By bertrand

CARDIAWAVE’S FIRST-IN-HUMAN TRIAL – FUS FOUNDATION A team of clinicians and researchers from France and the Netherlands published a Research Letter in Circulation to share feasibility results from the first 10 patients treated in a clinical trial using focused ultrasound to soften calcified aortic heart valves. To learn more >

MEDTECH INNOVATOR VIRTUAL PITCH EVENT

By bertrand

MEDTECH INNOVATOR VIRTUAL PITCH EVENT Our CEO Benjamin BERTRAND pitched in March at the MedTech Innovator Virtual Pitch event! It will be a new opportunity to connect with international investors and potential strategic partners. 

PREMIERS RESULTATS D’UN TRAITEMENT NON-INVASIF – AP-HP

By bertrand

PREMIERS RESULTATS D’UN TRAITEMENT NON-INVASIF – AP-HP Merci AP-HP, Assistance Publique – Hôpitaux de Paris pour votre communiqué de presse présentant les résultats préliminaires de notre étude clinique qui évalue la sécurité, la faisabilité et les performances de notre appareil Valvosoft®, un dispositif expérimental non-marqué CE. Merci à tous nos partenaires HEGP, AP-HP, Amphia Hospital, Physics for Medicine Paris, Institut Langevin, CNRS – Centre … Continued

AMEL KORSO-FECIANE, TEST BENCH ENGINEER

By bertrand

AMEL KORSO-FECIANE, TEST BENCH ENGINEER After being an intern for several months within our company and having successfully obtained her Healthcare technology sciences 2nd year Master’s Degree, Amel Korso-Feciane joined our R&D team as Test Bench Engineer in January.Welcome back!

1,500 FOLLOWERS ON LINKEDIN

By bertrand

1,500 FOLLOWERS ON LINKEDIN Our LinkedIn account has reached 1,500 followers! Thanks to all of you for your interest and your support! More exciting news to come.